TITLE

ALLERGAN/SANWA KAGAKU KENKYUSHO TO DEVELOP POSURDEX IN JAPAN

PUB. DATE
May 2005
SOURCE
Worldwide Biotech;May2005, Vol. 17 Issue 5, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on a licensing agreement signed by Allergan Inc. with Sanwa Kagaku Kenkyusho Co. Ltd. to develop and commercialize POSURDEX for the ophthalmic specialty market in Japan in 2005. Therapeutic application of POSURDEX; Value of Japan's annual macular edema market; Terms of the license agreement.
ACCESSION #
16896275

 

Related Articles

  • Allergan enters patent battle over generic version of brimonidine tartrate solution. Webb, Jennifer A. // Ophthalmology Times;9/15/2004, Vol. 29 Issue 18, p6 

    Reports that Allergan Inc. has filed a lawsuit against Alcon Laboratories Inc., claiming that the latter infringed upon the former's patents for brimonidine tartrate ophthalmic solution to manufacture a generic alternative to its Alphagan P drops. Details of the case; Comments from both parties.

  • In Brief.  // Ophthalmology Times;5/1/2005, Vol. 30 Issue 9, p6 

    The article focuses on recent developments related to ophthalmology, as of May 1, 2005. ISTA Pharmaceuticals Inc. is asking the U.S. Food and Drug Administration for permission to conduct a phase IIb clinical trial for ecabet sodium, a prescription eye drop for treating keratoconjunctivitis...

  • EXECUTIVE SUMMARY.  // Orange County Business Journal;4/4/2005, Vol. 28 Issue 14, p12 

    Reports developments on industries in California. Growth in the shares of Western Digital Corp. after it told investors that it would beat profit forecasts for its desktop drives; Agreement between Allergan Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. to develop and market the Posurdex...

  • Ketotifen drop designed to provide ocular itching relief. Bowers, Lois A. // Ophthalmology Times;11/1/2008, Vol. 33 Issue 21, p23 

    The article evaluates the opthalmic solution Refresh Eye Itch Relief from Allergan Inc.

  • VistaGen and Sanwa to research stem cell diabetes drugs.  // PharmaWatch: Biotechnology;December2004, Vol. 3 Issue 12, p17 

    Reports that VistaGen Therapeutics has signed a strategic research agreement with Sanwa Kagaku Kenkyusho Co. Ltd. to discover diabetes drug candidates. Terms of the deal; Benefits for both companies; Funded research payments that VistaGen would receive.

  • PacifiCare Contracts with Monarch, Continues Turnaround. Reed, Vita // Orange County Business Journal;04/16/2001, Vol. 24 Issue 16, p56 

    Reports the performance of medical companies in California. Contract of PacifiCare Health Systems Inc. with Monarch HealthCare; Approval of Allergan Inc. from Canadian health authorities for cosmetic treatment; Launch of the coronary treatment in Hoag Memorial Hospital Presbyterian.

  • Allergan to distribute keratome.  // Ophthalmology Times;06/15/2000, Vol. 25 Issue 12, p66 

    Focuses on the distribution agreement signed by Allergan with Surgical Instruments Systems AG. Information on the Amadeus microkeratome product; Comments from E.I. Pyott, president and chief executive officer of Allergan.

  • Agreements/contracts.  // Medical Device Daily;1/20/2010, Vol. 14 Issue 12, p5 

    This article reports on the extended agreement between Covidien and Allergan to jointly develop Allergan's Lap Band System.

  • Pieris Getting $10M Up Front in Allergan Ophthalmology Deal. Sheridan, Cormac // BioWorld International;9/23/2009, Vol. 14 Issue 38, p1 

    The article reports that Pieris AG is getting an up-front payment of 10 million dollars from Allergan Inc., as part of a licensing deal under which Allergan will gain access to its anticalin technology in ophthalmology indications. The agreement obliges Allergan to deploy its delivery...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics